Search - tctmd.com

Displaying 41 - 60 of 316

Sort: Relevancy | Date

News Daily News

Italian Registry Cautions Against TAVR in Low-Risk Patients

L.A. McKeown

May 16, 2016

News Industry News

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

May 02, 2016

News Daily News

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Todd Neale

April 27, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

April 26, 2016

News Industry News

FDA Approves World's Smallest Pacemaker for U.S. Patients

April 07, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Opinion Fellow Talk

Balancing the Bias: On Learning to Interact With Industry Reps as a Fellow

Luke Kohan, MD

March 29, 2016

News Industry News

St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads

March 29, 2016

News Industry News

St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker

March 09, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Industry News

Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans

February 21, 2016

News Daily News

FDA Advisors Recommend Comprehensive, Long-Term Study of Leadless Pacemakers

Yael L. Maxwell

February 18, 2016

News Industry News

St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology

February 16, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

Presentation

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Presenter: Oliver Husser

February 04, 2016

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

February 04, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

Advertisement

Italian Registry Cautions Against TAVR in Low-Risk Patients

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

FDA Approves World's Smallest Pacemaker for U.S. Patients

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Balancing the Bias: On Learning to Interact With Industry Reps as a Fellow

St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads

St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans

FDA Advisors Recommend Comprehensive, Long-Term Study of Leadless Pacemakers

St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content